dm+d
126155003
Refrigerated Storage
SandostatinNovartis Pharmaceuticals
In the event of an inadvertent temperature excursion the following data may be used:
The ampoules may be stored below 30°C for up to two weeks.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Sandostatin LARNovartis Pharmaceuticals
In the event of an inadvertent temperature excursion the following data may be used:
Sandostatin LAR may be stored below 25°C on the day of the injection
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
OctreotideRanbaxy Limited a Sun Pharmaceutical Company
In the event of an inadvertent temperature excursion the following data may be used:
Unopened ampoules/vials may be stored at 25°C for up to 4 weeks.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
OctreotideHospira UK Ltd (part of Pfizer)
In the event of an inadvertent temperature excursion the following data may be used:
In-house data from the manufacturer indicate that exposure of vials of octreotide acetate stored at room temperature (8°C – 25°C) for a maximum of 72 consecutive hours are stable until expiration date, if returned to storage between 2°C – 8°C.
Vials exposed to temperature excursions of >72 hours at room temperature (8°C – 25°C) are stable for either:
a) 6 months from original manufacturing date
b) 2 weeks at 25°C from initial temperature excursion.